Gefitinib Sandoz 250 mg filmom obložene tablete
| Name | Gefitinib Sandoz 250 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-844090380 |
| Active Substance | gefitinib |
| Composition | svaka tableta sadrži 250 mg gefitiniba |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 25.01.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/152 |
| Registration Number | 381-12-01/154-23-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EB01 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
